In homozygotes, ApoE4 alleles increase the susceptibility or lifetime risk of developing AD by favoring the conversion of APP into Aβ40 and Aβ42, thus reducing their clearance via the degradation pathway [33]. The gene discussed is APOE; the disease is Alzheimer disease.